1.
Sci Transl Med
; 16(753): eadl0998, 2024 Jun 26.
Article
in English
| MEDLINE
| ID: mdl-38924430
ABSTRACT
Drug repurposing can be cheaper and faster than developing new compounds. Yet, it remains underused, partially because of regulatory and intellectual property challenges. Policy-makers in the United States and Europe have created seven drug development programs that aim to overcome these challenges using a variety of different strategies.